/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Over the past 25 years, Dr. Cooper' career has focused on the evaluation and diagnosis of rare and undiagnosed cardiomyopathies especially autoimmune variants of myocarditis. He coordinated multicenter investigations including the 1995-97 international giant cell myocarditis registry, the giant cell myocarditis treatment trial, and led international teams on the role of endomyocardial biopsy in cardiovascular disease (AHA/ACC/ESC) and the global burden of myocarditis (WHO/Gates Foundation). In 2005 he co-founded the Myocarditis Foundation, a 501c3 corporation dedicated to support for affected families, education, and research in myocarditis (www.myocarditisfoundation.org).
